Fisher & Paykel Healthcare | FPH - Selling And Administration Expenses

Stock Price
31.75
Daily Change
-0.20 -0.63%
Monthly
3.86%
Yearly
7.08%
Q1 Forecast
31.33

Fisher & Paykel Healthcare reported NZD285.5M in Selling and Administration Expenses for its fiscal semester ending in December of 2025.





Selling And Administration Expenses Change Date
Cochlear AUD 449.4M 214.45M Dec/2025
CSL USD 1.23B 498M Dec/2025
Nanosonics AUD 53.78M 26.93M Dec/2025
Ramsay Health Care AUD 5.29B 3.2M Dec/2024
ResMed USD 275.7M 16.51M Dec/2025
Somnomed AUD 19.5M 353.23K Jun/2023
Sonic Healthcare AUD 2.52B 2.46B Dec/2024